Fernanda Mosele
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Patritumab deruxtecan in breast cancer treatment: a drug evaluation.
Journal: Future oncology (London, England)
Published: December 15, 2025
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 15, 2025
Genomic landscape of metastatic breast cancers in young adults: a liquid biopsy analysis of women aged 20-40 years.
Journal: Breast (Edinburgh, Scotland)
Published: October 17, 2025
Patritumab deruxtecan in HR+HER2- advanced breast cancer: a phase 2 trial.
Journal: Nature medicine
Published: March 31, 2025
Author Correction: Characterization and spatial distribution of infiltrating lymphocytes in medullary, and lymphocyte-predominant triple negative breast cancers.
Journal: NPJ breast cancer
Published: October 25, 2024
Characterization and spatial distribution of infiltrating lymphocytes in medullary, and lymphocyte-predominant triple negative breast cancers.
Journal: NPJ breast cancer
Published: December 08, 2023
Optimizing the potential of antibody-drug conjugates in oncology.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 29, 2023
Trastuzumab deruxtecan for breast cancer: do patients experience a comprehensive benefit?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 19, 2023
Last Updated: 09/26/2026